Position in AZN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$829,152,126
New position
Shares Held
4,204,199
first reported quarter
Ownership
0.271%
of shares outstanding
% of Portfolio
4.46%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026M&G PLC holds $1,488,143,891 across 11 Drug Manufacturers - General names. AZN ranks #1 (55.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
4,204,199 | $829,152,126 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
5,764,140 | $349,595,091 | |
| 3 | AMGN |
Amgen Inc
|
439,063 | $154,484,316 | |
| 4 | ABBV |
AbbVie Inc.
|
262,231 | $57,032,620 | |
| 5 | MRK |
Merck & Co., Inc.
|
298,044 | $35,851,712 | |
| 6 | JNJ |
Johnson & Johnson
|
76,011 | $18,580,128 | |
| 7 | PFE |
Pfizer Inc
|
546,673 | $15,350,577 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
95,757 | $13,345,653 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $829,152,126 | 4,204,199 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||